Sign inJoin waitlistJoin the waitlist

James Gulley

Co-Director · Clinical Center at the National Institutes of Health

Credentials: · · ·

History

Research

Androgen deprivation therapy for prostate cancer
Review · JAMA · 2005 · 841 citations
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer
Journal of Clinical Oncology · 2010 · 767 citations
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Journal of Clinical Oncology · 2017 · Last of 17 authors · 485 citations

Ravi Madan
144 papers · 8 as a fellow
WD
William Dahut
111 papers
PA
Philip Arlen
88 papers
Fatima Karzai
47 papers
William Figg
45 papers
CH
Christopher Heery
39 papers · 5 as a fellow
Marijo Bilusic
38 papers
Julius Strauss
34 papers · 1 as a fellow
Jason Redman
27 papers · 6 as a fellow
Charalampos Floudas
25 papers · 2 as a fellow
HP
Howard Parnes
23 papers
Ismail Turkbey
22 papers

Grants

E7 TCR-T Cell Therapy for HPV-Associated Cancers
National Cancer Institute · U01
PI · $1.9M · Rutgers Biomedical and Health Sciences
2024–2028
Developing Clinical, Immunologic and Radiographic Tools to Measure the Clinical Effect of Immunotherapy in Biochemically Recurrent Prostate Cancer
National Cancer Institute · U01
PI · $1.3M · Sloan-Kettering Inst Can Research
2016–2020
Cancer Immunotherapy
National Cancer Institute · ZIA
Contact PI · $22.4M · Division of Basic Sciences - Nci
Office of Sponsor and Regulatory Oversight
National Cancer Institute · ZID
Contact PI · $18.5M · Division of Basic Sciences - Nci

Clinical trials

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Principal investigator · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2028
N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer
Principal investigator · Withdrawn · Phase 2
National Cancer Institute (NCI)
2024
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
Principal investigator · Suspended
National Cancer Institute (NCI)
2023–2028
Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19
Principal investigator · Terminated
National Cancer Institute (NCI)
2022–2025